The following indicators were evaluated: 1) demographic characteristics, including age, sex, and underlying disease (hypertension and diabetes); 2) laboratory data, including hemoglobin, serum calcium, serum creatinine, albumin, globulin, serum/urine light chain protein, lactate dehydrogenase (LDH), and beta-2 microglobulin; 3) anti-myeloma therapy regimen; 4) duration of follow-up; 5) serum creatinine at the last follow-up evaluation, time of death, or dialysis; 6) serum calcium and albumin levels (Cobas Integra reagents; Roche Diagnostics, Switzerland).
Albumin-adjusted serum calcium was calculated using the following formula: serum albumin-corrected calcium (mg/dL) = total calcium (mg/dL) + 0.8 × [4 - albumin (g/dL)] [18 (link)–20 (link)].